Biogen (BIIB) PT Lowered to $200 at Barclays

April 25, 2024 3:31 AM EDT
Get Alerts BIIB Hot Sheet
Price: $209.83 -0.39%

Rating Summary:
    28 Buy, 15 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Barclays analyst Carter Gould lowered the price target on Biogen (NASDAQ: BIIB) to $200.00 (from $215.00) while maintaining a Equalweight rating.

You May Also Be Interested In





Related Categories

Analyst PT Change